Type 2 Diabetes Mellitus
11 drugs33,429 FAERS reportsMedDRA PT
GET
/api/v1/reaction/type-2-diabetes-mellitusReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D003924
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Source: U.S. National Library of Medicine — MeSH (Diabetes Mellitus, Type 2)
Drugs reporting Type 2 Diabetes Mellitus (11)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Triprolidine12244%
- 2Triclosan19839%
- 3Diatrizoate6112%
- 4Neomycin66910%
- 5Thiothixene115.0%
- 6Atorvastatin11,2724.6%
- 7Ziprasidone8814.4%
- 8Etrasimod664.3%
- 9Quetiapine5,8733.1%
- 10Povidone-iodine1152.8%
- 11Calcium14,1612.4%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Rheumatic Fever2 shared · 0.18
- Wound3 shared · 0.14
- Psoriatic Arthropathy3 shared · 0.12
- Pericarditis2 shared · 0.12
- C-reactive Protein Increased2 shared · 0.11
- Obesity2 shared · 0.11
- Tardive Dyskinesia2 shared · 0.09
- Diabetes Mellitus3 shared · 0.09
- Ill-defined Disorder2 shared · 0.07
- Pemphigus2 shared · 0.07
Literature
Recent PubMed references pinned to Diabetes Mellitus, Type 2 as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Experiences of People With Poorly Controlled Type 2 Diabetes Using Telemonitoring: Qualitative Study Embedded in a Feasibility Trial.JMIR formative research · 2026 · Giese IE, Laursen SH, Barington PF, et al.PMID 42207173DOI 10.2196/89964
- Explore the Causal Effect of SGLT2 Inhibition on Venous Thromboembolism Events: A Drug-Target Mendelian Randomization Study With Pharmacovigilance Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2026 · Liu J, Ma Z, Liu P, et al.PMID 42206520DOI 10.1177/10760296261457239
- Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway.Drug design, development and therapy · 2026 · Zhang Z, Niu D, Qiu W, et al.PMID 42206237DOI 10.2147/DDDT.S599539
- A familial case report of 17q12 recurrent deletion syndrome: clinical and molecular characterization.Frontiers in endocrinology · 2026 · Dvoryanchikov YV, Khusainova RI, Minniakhmetov IR, et al.PMID 42205255DOI 10.3389/fendo.2026.1819047
- Aerobic Exercise Preserves Retinal Integrity in Type 2 Diabetic Zebrafish in Association With Skeletal Muscle Mitochondrial Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026 · Gou S, Dai Z, Luo C, et al.PMID 42205088DOI 10.1096/fj.202602090R
- BRinging the Diabetes Prevention Program to GEriatric Populations in Spanish (BRIDGE-S): Assessing Acceptability Among Hispanic/Latino Adults in an Older Adult Center.Journal of primary care & community health · 2026 · De Leon E, Decaro K, De La Calle F, et al.PMID 42204762DOI 10.1177/21501319261439551
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.